|
Cadwell, K., Loke, P., 2025. Gene-environment interactions shape the host-microbial interface in inflammatory bowel disease. Nat. Immunol. 26, 1023-1035.
|
|
Cao, L., Wu, X.M., Hu, Y.W., Xue, N.N., Nie, P., Chang, M.X., 2018. The discrepancy function of NLRC5 isoforms in antiviral and antibacterial immune responses. Dev. Comp. Immunol. 84, 153-163.
|
|
Caruso, R., Lo, B.C., Nunez, G., 2020. Host-microbiota interactions in inflammatory bowel disease. Nat. Rev. Immunol. 20, 411-426.
|
|
Chen, J., Ruan, H., Ng, S.M., Gao, C., Soo, H.M., Wu, W., Zhang, Z., Wen, Z., Lane, D.P., Peng, J., 2005. Loss of function of def selectively up-regulates Δ113p53 expression to arrest expansion growth of digestive organs in zebrafish. Genes Dev. 19, 2900-2911.
|
|
Cohen, L.J., Cho, J.H., Gevers, D., Chu, H., 2019. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology 156, 2174-2189.
|
|
Iliev, I.D., Ananthakrishnan, A.N., Guo, C.J., 2025. Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. Nat. Rev. Microbiol. 23, 509-524.
|
|
Karayiannakis, A.J., Syrigos, K.N., Efstathiou, J., Valizadeh, A., Noda, M., Playford, R.J., Kmiot, W., Pignatelli, M., 1998. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J. Pathol. 185, 413-418.
|
|
Mankertz, J., Schulzke, J.D., 2007. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr. Opin. Gastroenterol. 23, 379-383.
|
|
Odenwald, M.A., Turner, J.R., 2017. The intestinal epithelial barrier: a therapeutic target? Nat. Rev. Gastroenterol. Hepatol. 14, 9-21.
|
|
Pahl, H.L., 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866.
|
|
Peterson, L.W., Artis, D., 2014. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14, 141-153.
|
|
Pham, L.N., Kanther, M., Semova, I., Rawls, J.F., 2008. Methods for generating and colonizing gnotobiotic zebrafish. Nat. Protoc. 3, 1862-1875.
|
|
Plichta, D.R., Graham, D.B., Subramanian, S., Xavier, R.J., 2019. Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host-microbiome relationships. Cell 178, 1041-1056.
|
|
Schirmer, M., Garner, A., Vlamakis, H., Xavier, R.J., 2019. Microbial genes and pathways in inflammatory bowel disease. Nat. Rev. Microbiol. 17, 497-511.
|
|
Viatour, P., Merville, M.P., Bours, V., Chariot, A., 2005. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30, 43-52.
|
|
Xu, Y., Zhang, Q., Miao, C., Dongol, S., Li, Y., Jin, C., Dong, R., Li, Y., Yang, X., Kong, B., 2019. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression. Cancer Med. 8, 351-362.
|
|
Zhao, S., Xia, J., Wu, X., Zhang, L., Wang, P., Wang, H., Li, H., Wang, X., Chen, Y., Agnetti, J., et al., 2018. Deficiency in class III PI3-kinase confers postnatal lethality with IBD-like features in zebrafish. Nat. Commun. 9, 2639.
|
|
Zou, Q., Gang, K., Yang, Q., Liu, X., Tang, X., Lu, H., He, J., Luo, L., 2018. The CCCH-type zinc finger transcription factor Zc3h8 represses NF-κB-mediated inflammation in digestive organs in zebrafish. J. Biol. Chem. 293, 11971-11983.
|